Keywords: rhone-poulenc, rorer, estalis, patch, approved, announced, marketing
Rhone-Poulenc Rorer's Estalis Patch Approved
Article | 13 October 1998
Rhone-Poulenc Rorer has announced marketing clearance in 12 EuropeanUnion countries for the hormone replacement therapy patch Estalis (17-beta estradiol and norethisterone ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
